BRAF alterations, especially V600E, have been studied intensively as potential diagnostic biomarkers for different types of cancers, including melanoma, colorectal cancer, papillary thyroid carcinoma and hairy cell leukaemia [40,42,43]. This evidence concerns the gene BRAF and thyroid gland papillary carcinoma.